Aurobindo Pharmaceutical Reports A Stable Q4
  • WebDesk BTVI
  • May 29 2019

Pharma major Aurobindo Pharma today reported a consolidated net profit of Rs 585 Cr, up 10.08% YoY, for the fourth quarter ended on March 31, 2019. Its consolidated revenue stood at Rs 5, 292 Cr, up 30.07% YoYand EBITDA is up by 32% at Rs 1,060 Cr YoY.